Goldman Sachs’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $35.1M | Buy |
|
|||||
|
2022
Q3 | $30.7M | Buy |
|
|||||
|
2022
Q2 | $6.94M | Buy |
|
|||||
|
2022
Q1 | $5.44M | Sell |
|
|||||
|
2021
Q4 | $4.47M | Sell |
|
|||||
|
2021
Q3 | $4.35M | Buy |
|
|||||
|
2021
Q2 | $4.8M | Sell |
|
|||||
|
2021
Q1 | $9.87M | Sell |
|
|||||
|
2020
Q4 | $7.48M | Buy |
|
|||||
|
2020
Q3 | $6.51M | Buy |
|
|||||
|
2020
Q2 | $4.92M | Buy |
|
|||||
|
2020
Q1 | $1.35M | Sell |
|
|||||
|
2019
Q4 | $2.6M | Sell |
|
|||||
|
2019
Q3 | $5.85M | Buy |
|
|||||
|
2019
Q2 | $5.91M | Buy |
|
|||||
|
2019
Q1 | $7.45M | Buy |
|
|||||
|
2018
Q4 | $4.26M | Buy |
|
|||||
|
2018
Q3 | $2.99M | Sell |
|
|||||
|
2018
Q2 | $4.12M | Buy |
|
|||||
|
2018
Q1 | $2.78M | Buy |
|
|||||
|
2017
Q4 | $2.11M | Sell |
|
|||||
|
2017
Q3 | $2.98M | Buy |
|
|||||
|
2017
Q2 | $2.15M | Buy |
|
|||||
|
2017
Q1 | $1.83M | Sell |
|
|||||
|
2016
Q4 | $2.9M | Buy |
|
|||||
|
2016
Q3 | $2.63M | Buy |
|
|||||
|
2016
Q2 | $1.28M | Buy |
|
|||||
|
2016
Q1 | $782K | Sell |
|
|||||
|
2015
Q4 | $2.65M | Sell |
|
|||||
|
2015
Q3 | $2.54M | Buy |
|
|||||
|
2015
Q2 | $2.67M | Sell |
|
|||||
|
2015
Q1 | $3.1M | Buy |
|
|||||
|
2014
Q4 | $1.3M | Sell |
|
|||||
|
2014
Q3 | $1.98M | Buy |
|
|||||
|
2014
Q2 | $2.13M | Buy |
|
|||||
|
2014
Q1 | $1.91M | Sell |
|
|||||
|
2013
Q4 | $5.3M | Buy |
|
|||||
|
2013
Q3 | $4.31M | Buy |
|
|||||
|
2013
Q2 | $3.09M | Buy |
|